Bioterrorism Week articles from November 2004

Bioterrorism Week archives from November 2004

Scientists have bionanotechnology recipe to find elusive bacteria.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A team of University of Florida (UF) researchers has created tiny hybrid particles that can speedily root out even one isolated E. coli bacterium lurking in ground beef or provide a crucial early...

U.S. defense department provides $4.9 million for pathogen research tool.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The Virginia Bioinformatics Institute (VBI) at Virginia Tech has received $4.9 million in additional funding from the U.S. Department of Defense (DoD) for the PathPort (Pathogen Portal) project, which...

Structural proteomics of the poxvirus family reviewed.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers review the structural proteomics of the poxvirus family in a recent issue of Artificial Intelligence in Medicine. According to a study from the United States, "Recent concerns over the...

Positive side effects of smallpox vaccination described.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A researcher describes the positive side effects of smallpox vaccination in a recent issue of the Journal of Veterinary Medicine Series B - Infectious Diseases and Veterinary Public Health. ...

Genetic relations among Francisella tularensis isolates analyzed.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Scientists have determined worldwide genetic relationships among Francisella tularensis isolates by multiple-locus variable-number tandem repeat analysis. According to a study from Sweden and the...

Prescriptions for antibiotics to prevent anthrax now uncommon.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Prescriptions for antibiotics that could be taken in advance to prevent against anthrax were uncommon among concerned patients after September 11, 2001 and the 2001 U.S. anthrax attacks, according to a...

Researchers begin evaluating efficacy of JuvImmune immunostimulant platform.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Juvaris BioTherapeutics, Inc., announced that researchers at the University of New Mexico have begun evaluating the efficacy of the JuvImmune immunostimulant platform against anthrax and small pox...

Study of primary care doctors' response to 2001 attacks shows prudent care.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Primary care physicians working only blocks away from the New York City anthrax attacks of October 2001 acted responsibly and rationally in the midst of the crisis, according to New York-Presbyterian...

Biotech firm lauds Nobel winner, announces olfactory-based government contract.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Joseph K. Pagano, chairman of the board of Sentigen Holding Corp. (SGHL), a biotechnology company, extended congratulations to Dr. Richard Axel, Sentigen's long term good friend and consultant, on being...

Biotech company representative testified about proposal for BioShield II.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) announced that Alan P. Timmins, AVI's president and COO, testified in a joint hearing before the U.S. Senate Committee on Health, Education, Labor and Pensions and the U.S....

District of Columbia EHMSA licenses VisualDx diagnostic software.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Logical Images, a developer of point-of-care medical-diagnostic software, announced that VisualDx will support clinicians at 10 District of Columbia hospital emergency departments and 20 District of...

NIH grants awards for the development of human antibody against anthrax.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Medarex (MEDX) announced that it has received two grants from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) to support Medarex's research and development of MDX-1303, a fully...

Ibis program granted three new government contracts for up to $10 million.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) announced that its Ibis program has been granted three new government contracts valued at up to $10 million for the continued development of its TIGER biosensor...

Comparative study of Legionnaire's disease published.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A team at the Institut Pasteur associated with the French National Center for Scientific Research (CNRS), and in collaboration with the National Reference Center for Legionella in Lyon, has compared the...

U.S. funding granted for new influenza drug.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Biota Holdings Limited announced that the U.S. government, via the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. National Institutes of Health (NIH), had awarded...

With shortage of flu vaccine, bioterrorism drill becomes more real.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The national shortage of flu vaccine has brought a bioterrorism drill planned for southeastern Colorado a lot closer to reality. Healthcare workers in 9 rural counties will go ahead with plans to...

Chemists give an old laboratory "bloodhound" a sharper nose.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Purdue University chemists have developed a fast, efficient means of analyzing chemical samples found on surfaces, resulting in a device that could impact everything from airport security to...

Four agencies share federal grant to help victims of torture.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Five years ago, the Mental Health Board of St. Louis, Missouri, was not aware that immigrants and refugees who had resettled in this city were wrestling with psychological wounds stemming from an often...

Terrorist suspects detained in Britain suffering mental damage.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Foreign terrorist suspects detained indefinitely without trial in Britain have suffered severe and possibly irreparable damage to their mental health, a group of psychiatrists who examined the men...

U.S. HHS awards $232 million in biodefense contracts for vaccine development.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- U.S. Health and Human Services (HHS) Secretary Tommy G. Thompson announced 4 new contracts totaling more than $232 million to fund development of new vaccines against 3 potential agents of bioterrorism:...

California scientists help bring study of smallpox virus into 'molecular age'.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Stanford University School of Medicine researchers have discovered details about the molecular effects of the smallpox virus, helping to shed light on why the disease is such a devastating killer. ...

Government to provide more funding for Anthim, an antianthrax drug.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Elusys Therapeutics, Inc., announced that the federal government will provide additional funding for Anthim, the company's antibody treatment for exposure to anthrax toxin. Elusys will receive $5...

Capsule of Bacillus anthracis behaves as type 2 antigen.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- The capsule of Bacillus anthracis behaves as a thymus-independent type 2 antigen. "Bacillus anthracis elaborates a homopolymeric capsule composed Of T-D-glutamic acid residues. Mice were immunized...

Report finds pharma, government and academia agree on bioterrorism danger.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- A report released finds wide agreement among experts from the pharmaceutical industry, government, and academia that the danger posed by bioterrorism and natural epidemics is "profoundly serious" and...

U.S. NIH allergy institute awards $50 million for recombinant protein vaccine.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Avecia has been awarded a U.S. $50.7 million contract for the development of a recombinant plague vaccine. The contract provides funds for pilot lot manufacture, release, testing and initial human...

Sublethal Francisella infection causes only marginal immunity.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis. ...

SAIS and CombiMatrix to jointly develop biothreat identification microarrays.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Acacia Research Corp. (ACTG) announced that its CombiMatrix group and Science Applications International Corp. (SAIC), an employee-owned research and engineering company, will work together to develop...

Bioassays company announces U.S. Army contract, new kinase Activity Assays.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- QTL Biosystems announced the introduction of its QTL LightSpeed Kinase platform and four new kinase Activity Assays. The kinase platform is built utilizing QTL's patented superquenching polymer...

Biotechnology company closes $50 million in series B financing.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- PharmAthene, Inc., announced the closing of $50 million in series B financing. The deal was led by MPM Capital and coled by Bear Stearns Health Innoventures. HealthCare Ventures, the sole Series A...

FDA releases 2004 produce safety action plan.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has announced that the final 2004 Produce Safety Action Plan entitled Produce Safety from Production to Consumption: 2004 Action Plan to Minimize Foodborne...

Food safety company acquires German distributor.
November 8, 2004... 2004 NOV 8 - (NewsRx.com & NewsRx.net) -- Neogen Corporation announced that it has acquired the distribution business of Biologische Analysensysteme GmbH (BAG), a company based in Lich, Germany. BAG has been a distributor of Neogen food safety...

Polyol osmolytes prevent thermal inactivation of anthrax antigen.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Polyol osmolytes prevent thermal inactivation of Bacillus anthracis protective antigen. "Protective antigen (PA) of Bacillus anthracis is the main immunogen of all anthrax vaccines. It is a highly...

New microarray test funded by NIH.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., announced that it would be developing a biodefense microarray test that can detect hundreds of top-priority bacterial and viral biological threats, such as anthrax and plague. The new...

Surge healthcare planning necessary for future epidemic and terrorist attacks.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Surge healthcare planning is necessary for future epidemic and terrorist attacks. According to investigators writing in the journal Annals of Emergency Medicine, "Recent terrorist and epidemic...

Rift Valley fever virus protein blocks interferon production.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. "Rift Valley fever virus (RVFV) is an important cause of epizootics and epidemics in...

Stevens-Johnson syndrome after smallpox vaccination reported.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Researchers report a case of Stevens-Johnson syndrome after immunization with smallpox, anthrax, and tetanus vaccines. According to a study from the United States, "A 19-year-old male military...

Anthrax vaccine award rescheduled.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., (VXGN.PK) announced that the award of a contract to supply 75 million doses of a recombinant anthrax vaccine to the U.S. government will be delayed up to November 5, 2004. VaxGen now...

Pharmaceutical company presents anthrax vaccine update.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BPA) announced that it presented an update on its patented calcium phosphate (CAP) nanotechnology in vaccine development - including an innovative vaccine for anthrax -...

DoD awards contract to develop multimodal biometric systems.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- International Biometric Group, LLC, (IBG) and Michigan State University were recently awarded a 6-month contract by the U.S. Department of Defense (DoD) through the United States Army Research Office's...

Proposal to digitally photograph every inch of land.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Solano County could become one of the few in California to digitally photograph every inch from the air, using money from the U.S. Department of Homeland Security. County supervisors are...

Cangene identified as sole-source supplier for anti-botulism drug.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Cangene Corporation reported that the U.S. Centers for Disease Control and Prevention (CDC) intends to negotiate a sole-source agreement with Cangene to provide up to 200,000 doses of botulinum toxin...

Arafat breaks Ramadan fast for treatment at urging of doctors.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Yasser Arafat has a large gallstone, a Palestinian hospital official said as the weakened Palestinian leader broke his Ramadan fast and underwent more medical tests at the urging of his doctors. ...

Company announces new, speedy gene detection method.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Roche scientists announced a new computational method to detect disease-causing genes in the Oct. 22 issue of Science. According to the announcement, this approach may accelerate the discovery of...

Mass spectrometer for complex analysis selected for R&D 100 Award.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- One of Thermo Electron Corporation's (TMO) flagship mass spectrometers, the Finnigan LTQ FT, has been selected by R&D Magazine as one of the top 100 innovative new products of the year. This...

Dose/age associated with translocation frequency in low-dose radiation exposure.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Dose, and age are associated with translocation frequency in low-dose radiation exposure. "Chromosome analysis using fluorescence in situ hybridization was undertaken on 294 retired workers from...

Kathrin U. Jansen, PhD, named senior VP and CSO at vaccine company.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., announced that Kathrin U. Jansen, PhD, the former executive director of microbial vaccine research for Merck Research Laboratories, has been named senior vice president of research and...

Muslims give $50,000 to New Jersey City Medical Center.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Four Muslim businessmen donated $50,000 to Jersey City Medical Center in New Jersey to fulfill their religious obligation to give to charity during the holy month of Ramadan. Mohamed Choukeir,...

Clinical development begun to study attenuated smallpox vaccine drug.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc. (VXGN.PK) announced that it has initiated a phase 1/2 clinical trial to evaluate the safety and immune response of its attenuated smallpox vaccine candidate, LC16m8. One of 4 clinical...

Agreement announced for PER.C6 technology for foot-and-mouth disease vaccines.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Dutch biotechnology company Crucell, NV, (CRXL) and Merial, an animal-health company, announced that they have entered into a license agreement for the utilization of Crucell's PER.C6 technology for...

Drugmaker and USAMRIID to study ATryn for viral hemorrhagic diseases.
November 15, 2004... 2004 NOV 15 - (NewsRx.com & NewsRx.net) -- Biotherapeutics, Inc., (GTCB) announced that it has signed a 2-year cooperative research and development agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases...

Acute radiation syndrome therapeutics manufacturer to respond to RFI.
November 22, 2004... 2004 NOV 22 - (NewsRx.com & NewsRx.net) -- Hollis-Eden Pharmaceuticals, Inc., (HEPH) announced plans to respond before the December 20, 2004, deadline to a Request for Information (RFI), issued by the U.S. Department of Health and Human...

Anthrax protective antigen predictive of serum anti-toxin activity.
November 22, 2004... 2004 NOV 22 - (NewsRx.com & NewsRx.net) -- Bacillus anthracis protective antigen is predictive of serum anti-toxin activity in patients with bioterrorism-related cutaneous or inhalation anthrax. According to recent research from the United...

Anthrax proteins associated with germination and outgrowth identified.
November 22, 2004... 2004 NOV 22 - (NewsRx.com & NewsRx.net) -- Scientists have identified Bacillus anthracis proteins associated with germination and early outgrowth by proteomic profiling of anthrax spores. According to a study from the United States, "The...

Potential return of smallpox, world's readiness discussed in journal article.
November 22, 2004... 2004 NOV 22 - (NewsRx.com & NewsRx.net) -- According to Elsevier, a publisher of scientific, technical and medical information, an article in a recent issue of International Journal of Infectious Diseases (IJID) discusses the potential return...

Significant progress reported on smallpox vaccine.
November 22, 2004... 2004 NOV 22 - (NewsRx.com & NewsRx.net) -- Bavarian Nordic released its third quarter accomplishments relating to the development, production and marketing of innovative vaccines that prevent and treat infectious diseases. "The company's...

U.S. to buy 75 million doses of vaccine.
November 22, 2004... 2004 NOV 22 - (NewsRx.com & NewsRx.net) -- The U.S. government says it is purchasing 75 million doses of a new-generation anthrax vaccine under an $877.5 million contract - the first awarded through a federal program to develop and stockpile...

Grant provides $3.5 million for anthrax vaccine study.
November 22, 2004... 2004 NOV 22 - (NewsRx.com & NewsRx.net) -- A Washington state research team has been awarded a $3.5 million federal grant to use a molecular detective technique to study and potentially improve the military's anthrax vaccine. Anthrax...

Formaldehyde-induced DNA adducts biomarkers of nasal cell formaldehyde exposure.
November 22, 2004... 2004 NOV 22 - (NewsRx.com & NewsRx.net) -- Formaldehyde-induced DNA adducts are biomarkers of nasal epithelial cell formaldehyde exposure. According to a study from the United States, "Formaldehyde (FA) is a mutagen that, at high...

U.S. FDA allows use of chlorine dioxide antimicrobial for fruits, vegetables.
November 22, 2004... 2004 NOV 22 - (NewsRx.com & NewsRx.net) -- Selective Micro Technologies is now allowed by the U.S. Food and Drug Administration (FDA) to market its chlorine dioxide antimicrobial agent for the purpose of washing fruits and vegetables. Now,...

Biopharmaceutical company announces new member of board of directors.
November 22, 2004... 2004 NOV 22 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., (VXGN.PK) announced that Myron M. Levine, MD, the co-founder and director of the University of Maryland School of Medicine's Center for Vaccine Development (CVD), has joined VaxGen's...

Oregon Health & Science University gets grant for TB research.
November 22, 2004... 2004 NOV 22 - (NewsRx.com & NewsRx.net) -- Researchers at Oregon Health & Science University (OHSU) have been given $4 million to help find a vaccine for tuberculosis. The grant comes from federal money targeted for bioterrorism research...

Vaccine protects cheetah and black rhinoceros against anthrax.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Researchers have developed a vaccine that protects cheetahs and rhinoceroses against anthrax. According to a study from England, Namibia, and the United States, "Institution of a policy of...

Elimination of partially unfolded state improves vaccine stability.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Elimination of a partially unfolded state improves the stability of a protein vaccine. "Ricin is a potent toxin presenting a threat as a biological weapon. The holotoxin consists of two...

Membrane proteins of virions protects against vaccinia virus.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions induced protective immunity to vaccinia virus. "Infectious intracellular and extracellular...

Myopericarditis reported following smallpox vaccination.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- The incidence of myopericarditis following smallpox vaccination was higher than expected. "Myopericarditis has been a rare or unrecognized event after smallpox vaccinations with the New York City...

Applications of Clostridium and Bacillus proteins reviewed.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Scientists review the biochemistry, biology, and applications of common Clostridium and Bacillus proteins in a recent issue of Microbiology and Molecular Biology Reviews. According to a study from...

Company gets $877.5 million U.S. government contract to supply anthrax vaccine.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc. (VXGN) announced that the U.S. government has awarded the company an $877.5 million contract to supply 75 million doses of anthrax vaccine for civilian defense. The contract, the...

Plasmid DNA vaccine protects against aerosolized anthrax spores.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores. According to a study from the United States, "DNA vaccines...

New Indianapolis airport terminal to have biohazard room.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- A new terminal at Indianapolis International Airport will include a biohazard containment room where public health workers could isolate international travelers suspected of carrying contagious...

Biodefense Laboratory gets BSL-3 certification under CDC/NIH requirements.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- VERSAR, Inc. (VSR) announced that its Biodefense Laboratory has been certified for Biosafety Level 3 operations under Center for Disease Control/National Institute of Health (CDC/NIH) requirements. ...

Work continues to prepare Nebraska for bioterrorist attack.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- From local veterinarians to federal health officials, anyone who can play a role in making Nebraska safer and better prepared for a possible bioterrorist attack is being called upon to help. And...

Company raises $11M to advance smallpox and other antiviral therapeutics.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Chimerix, Inc., an emerging biotechnology company developing orally available antiviral therapeutics, announced an $11 million private placement of its series C preferred stock. Frazier Healthcare...

Demegen changes name, adopts new stock symbol.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Demegen, Inc., (DGMI) announced that shareholders had approved changing the company's name to PAR Advance Technologies Corp. In addition, the company's new stock symbol is PRVG. PAR Advance...

EnvironmentalRx provides business update.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- EnvironmentalRx (EVRX) continues to show growth in revenues. EVRX has multiple revenue streams produced from its diversified products and services. Patented mold remediation and bioterrorism kits...

Trial results for spi-VECTM oral immunotherapeutic vaccine reported.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Microscience announced further significant results from a phase I clinical study of its spi-VECTM oral immunotherapeutic vaccine designed for the treatment of subjects chronically infected with the...

Research institute announces $12 million in NIH contracts for smallpox research.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- The La Jolla Institute for Allergy and Immunology announced that it received contracts totaling nearly $12 million from the National Institute of Allergy and Infectious Diseases (NIAID), part of the...

Ultrasensitive "optical nose" for chemicals developed.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- A laser-based method for identifying a single atom or molecule hidden among 10 trillion others soon may find its way from the laboratory to the real world. Developed by physicists at the U.S....

Mobile Medical launches mobile command center division.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Mobile Medical and Command Centers, Inc., has begun marketing specialized mobile command centers that can be used by municipalities during times of crisis, such as when traditional command centers have...

Molecular studies institute wins $4.8 million NIH contract for smallpox vaccine.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Torrey Pines Institute for Molecular Studies has received a 5-year, $4.8 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of...

Prime-boost strategy developed using Salmonella enterica Typhi.
November 29, 2004... 2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Researchers have developed a prime-boost strategy using recombinant Salmonella enterica serovar Typhi. According to recent research from the United States, "This study investigated the utility of...